The outlook of companies tied to the drug's legacy presents a intricate investment scenario . While the initial surge generated substantial returns , generic competition have significantly diminished https://porn775662.dsiblogger.com/74887848/copyright-s-flagship-product-and-pharma-a-risky-venture